Ad
ADXS - Advaxis Stock Trading
About | Advaxis (NASDAQ:ADXS)
Advaxis is a clinical stage biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. Advaxis immunotherapies are based on a novel platform technology using live, attenuated bacteria that are bio engineered to secrete an antigen/adjuvant fusion protein s that is designed to redirect the powerful immune response all human beings have to the bacterium to the cancer itself. ADXS HPV is currently being evaluated in four clinical trials for human papillomavirus HPV associated cancers: recurrent/refractory cervical cancer India , locally advanced cervical cancer GOG/NCI U.S. study, Clinical Trials.gov Identifier NCT , head amp neck cancer CRUK study, Clinical Trials.gov Identifier NCT , and anal cancer BrUOG study, Clinical Trials.gov Identifier NCT . Advaxis has over distinct immunotherapies in various stages of development, developed directly by Advaxis and through strategic collaborations with recognized centers of excellence such as: the National Cancer Institute, Cancer Research UK, the Wistar Institute, the University of Pennsylvania, the University of British Columbia, the Karolinska Institutet, and others.
Quote | Advaxis (NASDAQ:ADXS)
| Last: | $0.24 |
|---|---|
| Change Percent: | -18.45% |
| Open: | $0.29 |
| Close: | $0.24 |
| High: | $0.2902 |
| Low: | $0.2356 |
| Volume: | 11,640,473 |
| Last Trade Date Time: | 12/22/2021 04:55:26 pm |
News | Advaxis (NASDAQ:ADXS)
-
QualTek Services Inc. (QTEKQ) is expected to report for Q2 2023 Amerityre Corp (AMTY) is expected to report for quarter end 2023-06-30 BYD Co - Class H (BYDDF) is expected to report for quarter end 2023-06-30 Shionogi & Co. Ltd. ADR (SGIOY) is expected to report for Q1 2024 Ea...
-
Zovio Inc. (ZVOI) is expected to report for quarter end 2023-06-30 Sierra Grande Minerals Inc Ordinary Shares (SIERD) is expected to report for quarter end 2023-06-30 The Intergroup Corporation (INTG) is expected to report for Q1 2024 Fortescue Metals Group Ltd ADR (FSUGY) is expected...
Message Board Posts | Advaxis (NASDAQ:ADXS)
| Subject | By | Source | When |
|---|---|---|---|
| The only safe haven for $$$$ these days | hdwrsft | investorshub | 03/22/2023 5:15:04 PM |
| What a turd. CEO Ken is running this | Ryguy008 | investorshub | 03/20/2023 2:35:37 PM |
| Another massive bank shockingly failed. One day it's | hdwrsft | investorshub | 03/12/2023 6:03:14 AM |
| Just think, in just another 7 years, and | hdwrsft | investorshub | 02/14/2023 2:26:10 PM |
| If there is any justice in this universe, | HereToFightScams | investorshub | 01/11/2023 4:23:53 AM |
Ad
-
QualTek Services Inc. (QTEKQ) is expected to report for Q2 2023 Amerityre Corp (AMTY) is expected to report for quarter end 2023-06-30 BYD Co - Class H (BYDDF) is expected to report for quarter end 2023-06-30 Shionogi & Co. Ltd. ADR (SGIOY) is expected to report for Q1 2024 Ea...
-
Zovio Inc. (ZVOI) is expected to report for quarter end 2023-06-30 Sierra Grande Minerals Inc Ordinary Shares (SIERD) is expected to report for quarter end 2023-06-30 The Intergroup Corporation (INTG) is expected to report for Q1 2024 Fortescue Metals Group Ltd ADR (FSUGY) is expected...
-
Blue Water Biotech Inc. (BWV) is expected to report $-0.12 for Q2 2023 Lycos Energy Inc (MAAL) is expected to report for quarter end 2023-06-30 Esports Entertainment Group Inc. (GMBL) is expected to report $-2.92 for Q4 2023 SigmaTron International Inc. (SGMA) is expected to report fo...